Insights into Chemopreventive Effects of Rosmarinic Acid Against Aflatoxin B1-Induced Genotoxic Effects
Open Access
Abstract
In this study, the chemopreventive effects of rosmarinic acid (RA), a major phenolic acid of the plant Rosmarinus officinalis L., against the carcinogenic naturally occurring mycotoxin aflatoxin B1 (AFB1) were investigated using both in silico and in vitro approaches. The in silico investigation of the chemical reactions between rosmarinic acid and the carcinogenic metabolite of AFB1, aflatoxin B1 exo-8,9-epoxide (AFBO), was conducted by activation free energies calculations with DFT functionals M11-L and MN12-L, in conjunction with the 6-311++G(d,p) flexible basis set and implicit solvation model density (SMD), according to a newly developed quantum mechanics-based protocol for the evaluation of carcinogen scavenging activity (QM-CSA). Following the computational analyses, the chemoprotective effects of RA were further studied in vitro in human hepatocellular carcinoma HepG2 cells by analyzing its influence on AFB1-induced genotoxicity using a comet assay, γH2AX, and p-H3, while its impact on cell proliferation and cell cycle modulation was assessed using flow cytometry. Our computational results revealed that the activation free energy required for the reaction of RA with AFBO (14.86 kcal/mol) is significantly lower than the activation free energy for the competing reaction of AFBO with guanine (16.88 kcal/mol), which indicates that RA acts as an efficient natural scavenger of AFBO, potentially preventing AFB1-specific DNA adduct formation. The chemoprotective activity of RA was confirmed through in vitro experiments, which demonstrated a statistically significant (p < 0.05) reduction in AFB1-induced single- and double-strand breaks in HepG2 cells exposed to a mixture of AFB1 and RA at non-cytotoxic concentrations. In addition, RA reversed the AFB1-induced reduction in cell proliferation.Keywords
Funding Information
- Slovenian Research and Innovation Agency (ARIS) (Z4-60176, L7-60161, J2-60044, J1-60001, P2-0046, P1-0403, P2-0438, P1-0245, J1-4398, L2-4430, J3-4498, J7-4638, J1-4414, J3-4497, J4-4633, J1-50034, J7-50043, I0-E015, J1-60016)
- HyBReED (Z4-60176, L7-60161, J2-60044, J1-60001, P2-0046, P1-0403, P2-0438, P1-0245, J1-4398, L2-4430, J3-4498, J7-4638, J1-4414, J3-4497, J4-4633, J1-50034, J7-50043, I0-E015, J1-60016)
- AI4SCI (Z4-60176, L7-60161, J2-60044, J1-60001, P2-0046, P1-0403, P2-0438, P1-0245, J1-4398, L2-4430, J3-4498, J7-4638, J1-4414, J3-4497, J4-4633, J1-50034, J7-50043, I0-E015, J1-60016)
This publication has 73 references indexed in Scilit:
- Rosmarinic acid, the active component of Rubi Fructus, induces apoptosis of SGC-7901 and HepG2 cells through mitochondrial pathway and exerts anti-tumor effectNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Rosemary (Rosmarinus officinalis L.): extraction techniques, analytical methods and health-promoting biological effectsPhytochemistry Reviews, 2021
- Rosmarinic acid attenuates chromium‐induced hepatic and renal oxidative damage and DNA damage in ratsJournal of Biochemical and Molecular Toxicology, 2020
- Rosmarinic acid inhibits nicotine‐induced C‐reactive protein generation by inhibiting NLRP3 inflammasome activation in smooth muscle cellsJournal of Cellular Physiology, 2018
- Ki-67: more than a proliferation markerChromosoma, 2018
- Complementarity of phosphorylated histones H2AX and H3 quantification in different cell lines for genotoxicity screeningArchives of Toxicology, 2015
- Inhibitory Effects of Rosemary Extracts, Carnosic Acid and Rosmarinic Acid on the Growth of Various Human Cancer Cell LinesPlant Foods for Human Nutrition, 2010
- Prunella vulgaris extract and rosmarinic acid prevent UVB-induced DNA damage and oxidative stress in HaCaT keratinocytesArchives of Dermatological Research, 2009
- Protective effect of rosmarinic acid on V79 cells evaluated by the micronucleus and comet assaysJournal of Applied Toxicology, 2009
- Effects of rosmarinic acid against aflatoxin B1 and ochratoxin‐A‐induced cell damage in a human hepatoma cell line (Hep G2)Journal of Applied Toxicology, 2004